We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Separator Gel in Blood Collection Tubes Exhibit Anomalies

By LabMedica International staff writers
Posted on 03 Oct 2011
Clinical samples that have densities greater than that of separator gel in specimen tubes may exhibit gel flotation to the top of the specimen upon centrifugation.

Inappropriate separator gel flotation can occur in specimens with high protein content and for automated analytical systems this can lead to mechanical disruption and potential inaccurate result reporting upon aspiration into instrument sampling probes.

At the University of Arkansas for Medical Sciences (Little Rock, AR, USA), scientists have determined the relative specimen densities and estimated total protein contents at which specimen gel flotation would occur upon centrifugation in commonly used commercial specimen tubes. More...
They initiated a comparative study of separator gel density using prepared dextran solutions.

In order to investigate the impact of different specimen tubes on the frequency of gel flotation in the clinical laboratory, a survey was undertaken of all total protein results from 46, 808 routine clinical samples, spanning a one year period. Eleven serum samples in the previous year total protein-result database exhibited an estimated total protein content of greater than 14.06 g/dL and they thus were deemed to be at risk for gel flotation in specific serum specimen tubes.

Specific gravity of several dextran solutions was determined by direct hydrometry. The dextran solutions were introduced to serum and plasma lithium heparin BD Vacutainer (Becton, Dickinson and Company; Franklin Lakes, NJ, USA) specimen tubes and into Vacuette specimen tubes (Greiner Bio-One; Frickenhausen, Germany), containing separator gel. Following centrifugation, the specimen tubes were examined for gel flotation. The total protein content in clinical samples that would result in gel flotation was estimated for different specimen container types. Flotation was observed at a lower dextran solution density for Bio-One Vacuette Lithium-Heparin tubes than for the BD Lithium-Heparin Plasma Vacutainer SST tubes in both serum and plasma separator gel-specimen tubes.

Some differences were observed between lots of the same specimen tube types. In serum tubes, the range of specific gravity where gel flotation was observed was 1.054–1.057 for BD Vacutainers and 1.044–1.047 for Greiner Vacuette tubes. For the Lithium-heparin plasma tubes the results were 1.054–1.057 for Vacutainers and 1.047–1.048 for Vacuettes. The total protein content of the clinical sample described in the study for which gel flotation was observed in a Greiner plasma specimen but not a BD plasma specimen tube was 14.4 g/dL. No samples exhibited protein contents higher than 16.12 g/dL, an estimated total protein content that would result in gel flotation in both BD and Greiner serum specimen tubes. The study was published in September 2011 in the Archives of Pathology and Laboratory Medicine.

Related Links:

University of Arkansas for Medical Sciences
Becton, Dickinson and Company
Greiner Bio-One



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.